Single-cell analysis fails to find a functional link between the organization of chromatin domain organization and gene activity.

PM This week in cybersecurity: botnets, RCE flaws, AI-driven attacks, stealers, and more. Fast, no-fluff roundup.

New collaboration structure achieves meaningfully improved financial terms and flexibility for Galapagos Following this transaction, the Company will continue to have a majority of its cash remaining ...

What's CODE SWITCH? It's the fearless conversations about race that you've been waiting for. Hosted by journalists of color, our podcast tackles the subject of race with empathy and humor. We explore ...

a binding term sheet granting the Company licenses to certain intellectual property rights relating to Ouro's research programs, including Ouro's lead program of gamgertamig for development purposes, ...

A375, HEK293T, Sk-Mel-3 and Sk-Mel-24 cell lines were obtained from the American Type Culture Collection. A375 and HEK293T cells were maintained in ...

BACKGROUND: Preeclampsia affects approximately 1 in 10 pregnancies, leading to severe complications and long-term health ...

Free with your TV subscription. More Information and FAQ NOW: Washington Journal NOW: Prime Minister's Question Time NOW: HUD Secretary Scott Turner Speaks at CPAC in Grapevine, Texas Wall Street ...

Mechelen, Belgium; March 31, 2026, 7.30 CET; regulated information – Announcement in application of Article 7:97, §4/1 of the BCCA - Galapagos NV (Euronext & NASDAQ: GLPG) (“Galapagos” or the“Company” ...

Gamgertamig (OM336) is a clinical‑stage BCMAxCD3 T cell engager designed to enable rapid and deep plasma and B‑cell depletion following a short duration, subcutaneously administered treatment course.